Agios Pharmaceuticals
AGIO
AGIO
215 hedge funds and large institutions have $3.61B invested in Agios Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
215
Holders Change
+18
Holders Change %
+9.14%
% of All Funds
4.42%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
47
Increased
65
Reduced
62
Closed
27
Calls
$28.9M
Puts
$19.2M
Net Calls
+$9.68M
Net Calls Change
+$2.56M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$175M |
| 2 |
BlackRock
New York
|
$268M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
$85.1M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
$17.3M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
$16M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$300M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$5.53M |
| 3 |
UBS AM
Chicago,
Illinois
|
$4.18M |
| 4 |
HM
HealthCor Management
New York
|
$0 |
| 5 |
Jennison Associates
New York
|
$18.9M |
